C7 Purification Protocol

Overview Published Data Featured Services Feature Products

Encoded by the C7 gene in humans, complement component 7 (C7) is a component of the complement system involved in the innate immune system. As a part of the membrane attack complex (MAC), C7 can cause cell lysis and death by forming a hole in the surface of pathogens. For an in-depth study of C7, Creative Biolabs has developed the C7 purification protocol for our clients all over the world.

C7 Purification

Flow chart of C7 purification protocol. Fig.1 Flow chart of C7 purification protocol. (Creative Biolabs)

Based on the established experimental method, we have been able to proficiently purify C7 to carry out the next work. We can also provide a series of products and services to meet the customer’s project and assay-specific requirements.

To learn more details, you can get access with the following links:

Published Data

Detection of a variant form of C7 and screening of C7aa residues in the visualized variant. (OA Literature)Fig.2 Identification of a C7 variant and analysis of amino acid residues within the visualized sequence alteration.1

The purification process for C7 must be meticulously controlled to ensure the protein maintains its structural and functional integrity. The latest purification methods use a series of chromatography steps beginning with affinity-based capture and followed by ion-exchange refinement to separate C7 from plasma-derived or recombinant solutions. The primary technical issues include reducing proteolytic breakdown while maintaining glycosylation structures, which are vital for binding performance. SEC-MALS and SDS-PAGE analytical techniques demonstrate monodispersity and glycan features, while functional assays prove complement-dependent lytic function. The use of low-temperature processing along with protease inhibitors greatly improves yield, which becomes especially important during therapeutic application scaling.

Featured Services

Feature Products

Cat# Product Type Product Name Specie Reactivity Applications Inquiry
CTS-006 Serum Human Complement Serum (Pooled) Human Complement fixation assays; Haemolysis Assays INQUIRY
CTS-001 Serum Guinea Pig Complement Serum Guinea pig Complement fixation assays; Haemolysis Assays INQUIRY
CTR-001 Antibody Hemolysin (Rabbit Anti-Sheep Cell Hemolysin) Sheep Complement fixation assays; Haemolysis Assays INQUIRY
CTP-461 Protein Native Human Complement C1q Protein Human ELISA; Functional Assays INQUIRY
CTP-463 Protein Native Mouse Complement C1q Protein Mouse ELISA; Functional Assays INQUIRY
CTMM-0322-JL15 Antibody Mouse Anti-Human C1q Monoclonal Antibody (TJL-03) [HRP] Human WB; IHC; ELISA INQUIRY
CTP-051 Protein Native Human Complement C3b Protein Human ELISA; Functional Assays INQUIRY
CTP-456 Protein Native Cynomolgus Monkey Complement C3b Protein Cynomolgus Monkey ELISA; Functional Assays INQUIRY

Reference

  1. Massri, Mariam, et al. "Complement C7 and clusterin form a complex in circulation." Frontiers in Immunology 15 (2024): 1330095. Distributed under an Open Access license CC BY 4.0, without modification.

If you are interested in our services and products, please do not hesitate to contact us for more information.

Please note that our protocols are only for your reference!

For Research Use Only.
Support

Online Inquiry